American Association of Bioanalysts
professional association committed to the pursuit of excellence in clinical lab services.
Based in MO
AI Overview
With $2.5M in lobbying spend across 34 quarterly filings, American Association of Bioanalysts is a significant lobbying presence. Their lobbying covers 2 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $280K |
| 2019 | $280K |
| 2020 | $350K |
| 2021 | $210K |
| 2022 | $500K |
| 2023 | $280K |
| 2024 | $280K |
| 2025 | $280K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues
Protecting Access to Medicare Beneficiaries Act of 2014, H.R. 4302
P.L. 113-93
Reimbursement for clinical laboratories
Clinical Laboratory Fee Schedule (CLFS)
Protecting Access to Medicare Beneficiaries Act of 2014, HR 4302
P.L. 113-93
Reimbursement for clinical laboratories
Clinical Laboratory Fee Schedule (CLFS)
Eliminating Kickbacks in Recovery Act (EKRA) of 2018
Protecting Access to Medicare Beneficiaries Act of 2014, HR 4302
P.L. 113-93
Reimbursement for clinical laboratories
Clinical Laboratory Fee Schedule (CLFS)
Eliminating Kickbacks in Recovery Act (EKRA) of 2018
LAB Act (HR 3584)
Surprise Billing
COVID-19
PL 116-136: CARES Act
PL 116-127: Family First Coronavirus Response Act
PL 116-127: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
COVID-19
PL 116-136: CARES Act
PL 116-127: Family First Coronavirus Response Act
PL 116-123: Coronavirus Preparedness and Response Supplemental
PL 116-139: PPP and Health Care Enhancement Act
Medicare Clinical Laboratory Fee
Schedule Issues
P.L. 113-93, Protecting Access to Medicare Beneficiaries Act of 2014
P.L. 115-271, SUPPORT for Patients and Communities Act (EKRA)
COVID-19 supplies and other issues
Medicare Clinical Laboratory Fee
Showing 8 of 15 unique descriptions from filings.
Related Analysis
Related Investigations
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.